Xenetic Biosciences, Inc. XBIO

2.37 (0.10) (4.05%) as of 25 Sep
Market cap
$5.8M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 0.00 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio 0.00 0.00 — 0.48 29.85 11.42 2.54 2.15 2.46 1.24
P/FCF ratio 0.00 11.09 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF (8.67) 3.40 — (2.45) (13.67) (9.09) (5.78) (6.88) (9.12) (15.21)
P/B ratio 2.48 1.15 — 0.24 1.07 0.72 0.32 0.56 1.02 0.50
EV/Sales 0.00 0.00 — (0.73) 3.54 (4.27) (5.13) (1.38) 0.00 (1.40)
EV/EBITDA 0.00 0.00 — 0.65 0.00 0.87 1.31 0.78 0.00 1.48
EV/FCF (4.22) 8.08 — 0.98 (0.36) 1.05 1.88 0.86 0.00 1.83
Current Ratio 4.47 3.03 0.75 7.84 13.20 13.18 12.72 11.84 7.37 8.32
Net Debt/EBITDA 0.09 1.58 0.09 1.08 0.83 3.19 1.96 1.99 1.47 2.78
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (511.45%) (23.60%) (60.31%) (133.18%) (74.05%) (36.89%) (40.91%) (35.28%) (50.13%) (40.01%)
ROA (307.49%) (17.91%) (43.46%) (100.39%) (62.74%) (34.22%) (37.95%) (32.65%) (45.24%) (35.12%)
ROIC (245.91%) (25.63%) (49.03%) (117.32%) (1,204.18%) (2,025.80%) (763.68%) (347.32%) 0.00% 0.00%
Return on Tangible Assets (893.94%) (90.59%) 1,821.48% (186.65%) (95.06%) (32.63%) (52.09%) (47.11%) (69.56%) (37.86%)
Average Days of Receivables 365.00 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield (136.38%) (22.64%) — (672.30%) (82.84%) (42.31%) (154.10%) (77.03%) (64.41%) (73.27%)
Free Cash Flow Yield (21.95%) 9.02% — (155.77%) (32.71%) (35.72%) (107.06%) (75.37%) (45.78%) (61.87%)
Free Cash Flow per Share (142.23) 20.57 (85.20) (22.43) (6.68) (4.61) (3.27) (2.69) (1.83) (1.34)
Book value per Share 261.22 198.08 131.12 60.36 19.11 17.90 9.59 6.41 3.90 4.35
Free Cash Flow (8.80) 1.48 (6.44) (6.40) (4.27) (4.74) (4.65) (4.11) (2.82) (2.29)
EV/EBIT 0.00 0.00 — 0.48 0.00 0.86 1.30 0.78 0.00 1.48
Other line items

Show all line items

Columns are period end dates